Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 3
2008 1
2009 3
2010 2
2011 1
2012 1
2013 2
2014 3
2015 3
2016 4
2017 3
2018 4
2019 6
2020 3
2021 6
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Disruptive Technology: CRISPR/Cas-Based Tools and Approaches.
Patsali P, Kleanthous M, Lederer CW. Patsali P, et al. Among authors: lederer cw. Mol Diagn Ther. 2019 Apr;23(2):187-200. doi: 10.1007/s40291-019-00391-4. Mol Diagn Ther. 2019. PMID: 30945167 Free PMC article. Review.
Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi.
Cavazza A, Hendel A, Bak RO, Rio P, Güell M, Lainšček D, Arechavala-Gomeza V, Peng L, Hapil FZ, Harvey J, Ortega FG, Gonzalez-Martinez C, Lederer CW, Mikkelsen K, Gasiunas G, Kalter N, Gonçalves MAFV, Petersen J, Garanto A, Montoliu L, Maresca M, Seemann SE, Gorodkin J, Mazini L, Sanchez R, Rodriguez-Madoz JR, Maldonado-Pérez N, Laura T, Schmueck-Henneresse M, Maccalli C, Grünewald J, Carmona G, Kachamakova-Trojanowska N, Miccio A, Martin F, Turchiano G, Cathomen T, Luo Y, Tsai SQ, Benabdellah K; COST Action CA21113. Cavazza A, et al. Among authors: lederer cw. Mol Ther Nucleic Acids. 2023 Oct 29;34:102066. doi: 10.1016/j.omtn.2023.102066. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 38034032 Free PMC article. Review.
Editorial: Mutation-Specific Gene Editing for Blood Disorders.
Lederer CW, Genovese P, Miccio A, Philipsen S. Lederer CW, et al. Front Genome Ed. 2021 Sep 29;3:761771. doi: 10.3389/fgeed.2021.761771. eCollection 2021. Front Genome Ed. 2021. PMID: 34713270 Free PMC article. No abstract available.
Sex-specific transcriptional profiles identified in β-thalassemia patients.
Nanou A, Toumpeki C, Fanis P, Bianchi N, Cosenza LC, Zuccato C, Sentis G, Giagkas G, Stephanou C, Phylactides M, Christou S, Hadjigavriel M, Sitarou M, Lederer CW, Gambari R, Kleanthous M, Katsantoni E. Nanou A, et al. Among authors: lederer cw. Haematologica. 2021 Apr 1;106(4):1207-1211. doi: 10.3324/haematol.2020.248013. Haematologica. 2021. PMID: 32817281 Free PMC article. No abstract available.
Recent trends in the gene therapy of β-thalassemia.
Finotti A, Breda L, Lederer CW, Bianchi N, Zuccato C, Kleanthous M, Rivella S, Gambari R. Finotti A, et al. Among authors: lederer cw. J Blood Med. 2015 Feb 19;6:69-85. doi: 10.2147/JBM.S46256. eCollection 2015. J Blood Med. 2015. PMID: 25737641 Free PMC article. Review.
A Tribute to George Stamatoyannopoulos.
Srivastava A, Kay MA, Athanasopoulos T, Angastiniotis M, Anagnostopoulos A, Karponi G, Yannaki E, Zon LI, Lederer CW, Phylactides MS, Kleanthous M. Srivastava A, et al. Among authors: lederer cw. Hum Gene Ther. 2016 Apr;27(4):280-6. doi: 10.1089/hum.2016.29025.gst. Hum Gene Ther. 2016. PMID: 27074151 No abstract available.
47 results